# OnCo record nct02338050 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02338050/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02338050", "NCT02338050" ;
  schema:name "Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and Minimal Residual Disease Prior to Allogeneic Hematopoietic Stem Cell Transplantation"@en ;
  schema:description "A phase 2 trial of Moxetumomab pasudotox in Acute lymphoblastic leukaemia, run by Center for International Blood and Marrow Transplant Research, recorded as terminated on the registry."@en ;
  schema:url <https://onco.cc/trials/nct02338050/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02338050> ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:drugs <https://onco.cc/drugs/moxetumomab-pasudotox/> .